MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.
Adaptor Proteins, Signal Transducing
/ deficiency
Angiomotins
/ metabolism
Breast Neoplasms
/ metabolism
Cadherins
/ metabolism
Carcinogenesis
/ metabolism
Cell Adhesion Molecules
/ deficiency
Cell Line, Tumor
Cell Proliferation
Epithelial Cells
/ metabolism
Female
Guanylate Kinases
/ deficiency
Humans
Phenotype
Protein Binding
Signal Transduction
Stress, Physiological
YAP-Signaling Proteins
/ metabolism
beta Catenin
/ metabolism
p38 Mitogen-Activated Protein Kinases
/ metabolism
rho-Associated Kinases
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 03 2021
11 03 2021
Historique:
received:
05
08
2020
accepted:
24
02
2021
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Alterations to cell polarization or to intercellular junctions are often associated with epithelial cancer progression, including breast cancers (BCa). We show here that the loss of the junctional scaffold protein MAGI1 is associated with bad prognosis in luminal BCa, and promotes tumorigenesis. E-cadherin and the actin binding scaffold AMOTL2 accumulate in MAGI1 deficient cells which are subjected to increased stiffness. These alterations are associated with low YAP activity, the terminal Hippo-pathway effector, but with an elevated ROCK and p38 Stress Activated Protein Kinase activities. Blocking ROCK prevented p38 activation, suggesting that MAGI1 limits p38 activity in part through releasing actin strength. Importantly, the increased tumorigenicity of MAGI1 deficient cells is rescued in the absence of AMOTL2 or after inhibition of p38, demonstrating that MAGI1 acts as a tumor-suppressor in luminal BCa by inhibiting an AMOTL2/p38 stress pathway.
Identifiants
pubmed: 33707576
doi: 10.1038/s41598-021-85056-1
pii: 10.1038/s41598-021-85056-1
pmc: PMC7952706
doi:
Substances chimiques
AMOTL2 protein, human
0
Adaptor Proteins, Signal Transducing
0
Angiomotins
0
Cadherins
0
Cell Adhesion Molecules
0
YAP-Signaling Proteins
0
YAP1 protein, human
0
beta Catenin
0
rho-Associated Kinases
EC 2.7.11.1
p38 Mitogen-Activated Protein Kinases
EC 2.7.11.24
Guanylate Kinases
EC 2.7.4.8
MAGI1 protein, human
EC 2.7.4.8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5752Références
Neoplasia. 2016 Jan;18(1):10-24
pubmed: 26806348
Anticancer Res. 2014 Jul;34(7):3251-6
pubmed: 24982328
BMC Biol. 2010 Apr 27;8:47
pubmed: 20515460
J Cell Biol. 1991 Apr;113(1):173-85
pubmed: 2007622
Oncogene. 2015 Feb 5;34(6):681-90
pubmed: 24531710
Eur J Cancer. 2000 Aug;36(13 Spec No):1607-20
pubmed: 10959047
FEBS J. 2015 May;282(10):1841-57
pubmed: 25728574
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11930-5
pubmed: 21730131
Sci Signal. 2018 Apr 10;11(525):
pubmed: 29636389
Cancer Sci. 2013 Mar;104(3):313-20
pubmed: 23279616
Cancer Cell. 2018 Jun 11;33(6):1094-1110.e8
pubmed: 29805078
Nat Commun. 2014 Aug 01;5:4557
pubmed: 25080976
Genes Dev. 2013 Feb 15;27(4):355-71
pubmed: 23431053
Mol Cell Biol. 2003 Jun;23(12):4267-82
pubmed: 12773569
Cell. 2011 Nov 11;147(4):759-72
pubmed: 22078877
Exp Cell Res. 2002 May 1;275(2):155-70
pubmed: 11969287
Development. 2015 Mar 15;142(6):1102-12
pubmed: 25725070
Oncogene. 2012 Mar 1;31(9):1196-206
pubmed: 21785460
Mol Cell Proteomics. 2014 Jan;13(1):119-31
pubmed: 24126142
Cancers (Basel). 2020 Jan 16;12(1):
pubmed: 31963297
Curr Biol. 2012 Oct 23;22(20):1891-9
pubmed: 22981773
J Cell Sci. 2016 Sep 15;129(18):3396-411
pubmed: 27521426
Cancers (Basel). 2019 Aug 19;11(8):
pubmed: 31430951
Oncogene. 2008 Nov 24;27(55):6920-9
pubmed: 19029934
Cell Cycle. 2006 Aug;5(16):1799-807
pubmed: 16929185
Dev Cell. 2017 Nov 6;43(3):305-317.e5
pubmed: 29112851
Biotechnol J. 2008 Mar;3(3):370-7
pubmed: 18064608
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
Dev Cell. 2018 Oct 8;47(1):3-19
pubmed: 30300588
Pharmacol Ther. 2018 Jun;186:60-72
pubmed: 29305295
Cell Rep. 2015 Oct 20;13(3):524-532
pubmed: 26456820
PLoS One. 2011;6(12):e26182
pubmed: 22180774
Curr Opin Cell Biol. 2018 Feb;50:42-49
pubmed: 29454273
Sci Rep. 2020 Apr 27;10(1):7098
pubmed: 32341407
Cell Rep. 2017 Aug 8;20(6):1435-1447
pubmed: 28793266
Cell. 2011 Mar 4;144(5):782-95
pubmed: 21376238
Nature. 2010 Dec 16;468(7326):968-72
pubmed: 21107320
Oncogene. 2017 Nov 23;36(47):6649-6657
pubmed: 28783172
Cell Death Differ. 2017 Sep;24(9):1488-1501
pubmed: 28644436
Sci Rep. 2017 Aug 8;7(1):7548
pubmed: 28790366
Mol Biol Cell. 2019 Feb 1;30(3):411-426
pubmed: 30540525
Cancer Cell. 2016 Jun 13;29(6):783-803
pubmed: 27300434
Nat Rev Cancer. 2009 Aug;9(8):537-49
pubmed: 19629069
Cancer Cell. 2007 Feb;11(2):191-205
pubmed: 17292829
Breast Cancer Res. 2011 Aug 12;13(4):215
pubmed: 21884641
Curr Biol. 2018 Apr 23;28(8):R445-R457
pubmed: 29689229
Annu Rev Genet. 2018 Nov 23;52:65-87
pubmed: 30183404
Int J Hematol. 2018 Mar;107(3):337-344
pubmed: 29043551
Genes Dev. 2011 Jan 1;25(1):51-63
pubmed: 21205866
Nature. 2019 Sep;573(7774):439-444
pubmed: 31485072
J Invest Surg. 2012 Apr;25(2):93-9
pubmed: 21942217
Biochim Biophys Acta. 2012 Aug;1826(1):23-31
pubmed: 22440943
EMBO Rep. 2016 Feb;17(2):188-201
pubmed: 26691213
Curr Opin Cell Biol. 2016 Oct;42:94-101
pubmed: 27236618
Br J Cancer. 2016 Nov 8;115(10):1223-1233
pubmed: 27685445
Science. 2015 May 29;348(6238):1024-7
pubmed: 26023140
Science. 2002 Dec 6;298(5600):1955-9
pubmed: 12471248
Mod Pathol. 2001 May;14(5):458-64
pubmed: 11353057
Sci Rep. 2017 Aug 25;7(1):9540
pubmed: 28842668
Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352
pubmed: 32300252
Cancer Cell. 2014 Apr 14;25(4):484-500
pubmed: 24684847
Sci Rep. 2017 Apr 13;7:46326
pubmed: 28406163
Nat Commun. 2014 May 07;5:3743
pubmed: 24806444
Cell Mol Life Sci. 2016 Sep;73(18):3535-53
pubmed: 27151512
J Biol Chem. 2005 Oct 14;280(41):34859-69
pubmed: 16043488
Nat Commun. 2017 Oct 18;8(1):1030
pubmed: 29044161
Biochim Biophys Acta. 2005 Aug 15;1745(1):131-44
pubmed: 16019084
Sci Signal. 2011 May 24;4(174):ra33
pubmed: 21610251
Mol Cell. 2013 Apr 11;50(1):43-55
pubmed: 23453810
J Biol Chem. 2011 Mar 4;286(9):7018-26
pubmed: 21224387
PLoS One. 2016 Apr 13;11(4):e0153259
pubmed: 27074039
Sci Signal. 2013 Nov 19;6(302):rs15
pubmed: 24255178
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 May;36(5):381-5
pubmed: 21685691
Langmuir. 2020 Jun 2;36(21):5709-5716
pubmed: 32427478
Oncogene. 2001 Feb 15;20(7):819-27
pubmed: 11314016
J Virol. 2014 Jul;88(13):7155-69
pubmed: 24696483
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Oncogene. 2012 Jan 5;31(1):48-59
pubmed: 21666716